KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Net Margin (2019 - 2025)

Historic Net Margin for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to 0.57%.

  • GoodRx Holdings' Net Margin fell 14600.0% to 0.57% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.97%, marking a year-over-year increase of 60200.0%. This contributed to the annual value of 2.07% for FY2024, which is 32500.0% up from last year.
  • Latest data reveals that GoodRx Holdings reported Net Margin of 0.57% as of Q3 2025, which was down 14600.0% from 6.32% recorded in Q2 2025.
  • In the past 5 years, GoodRx Holdings' Net Margin registered a high of 30.99% during Q2 2023, and its lowest value of 22.28% during Q3 2022.
  • Its 5-year average for Net Margin is 0.64%, with a median of 0.57% in 2025.
  • As far as peak fluctuations go, GoodRx Holdings' Net Margin surged by 1755400bps in 2021, and later plummeted by -276600bps in 2024.
  • Over the past 5 years, GoodRx Holdings' Net Margin (Quarter) stood at 18.72% in 2021, then soared by 94bps to 1.07% in 2022, then crashed by -1128bps to 13.16% in 2023, then soared by 126bps to 3.39% in 2024, then tumbled by -83bps to 0.57% in 2025.
  • Its Net Margin stands at 0.57% for Q3 2025, versus 6.32% for Q2 2025 and 5.45% for Q1 2025.